Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition.
Badreldin HA, Alsuhebany N, Alzahrani M, Alshehri AM, Aldoughaim M, Alqifari S, Yassin O, Alfehaid L, Alqahtani T.
Badreldin HA, et al. Among authors: alqifari s.
Curr Res Pharmacol Drug Discov. 2024 Mar 14;6:100179. doi: 10.1016/j.crphar.2024.100179. eCollection 2024.
Curr Res Pharmacol Drug Discov. 2024.
PMID: 38545505
Free PMC article.
Review.